N- (3,5- bis(trifluoromethyl)phenyl)(2- chloro- 4- (trifluoromethyl)pyrimidin- 5- yl)carboxamide
inhibits transcription mediated by NF-kappaB and AP-1; structure in first source
Also Known As:
2-chloro-4-trifluoromethylpyrimidine-5-(N-(3',5'-bis(trifluoromethyl)phenyl)carboxamide); N-bisCF3Ph CCF3PC
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results